Processing…
Success! You're on the list.
NEWSLETTER

Processing…
Success! You're on the list.

Phlo acquires Truepill UK to boost its digital pharmacy services

Phlo
Photo Credit: Phlo

Boosted by the Covid-19 pandemic and the ever-evolving consumer preferences, digital pharmacy has only seen exponential growth and it even continues to see an upward trajectory in the post pandemic world.

Seen as a step in the right direction, Scottish digital pharmacy startup Phlo has acquired the UK arm of US-based healthcare unicorn Truepill. The acquisition comes after the startup’s £10M Series A funding led by Scotland-based investment firm Thairm Bio with participation from Scottish Enterprise and a number of angel investors.

The acquisition will help Phlo to extend the geographic scope of its operations with ambitions to begin same-day on-demand drug delivery in Manchester, in addition to existing services in Birmingham and London.

Apart from that, the healthtech startup has also acquired the Truepill UK’s technology stack including their full set of Application Programming Interfaces (APIs) and prescribing technology. 

In a press note, the company claimed that once connected, Phlo’s technology will allow for the direct prescribing, dispensing, and delivery of prescribed and over-the-counter medications and therapies to users of these platforms.

As part of the deal’s business collaboration, Phlo has agreed to support Truepill’s US partners if any of them decide to enter the UK market. The organisations have also agreed to pursue additional cooperative projects as needed.

Phlo Digital Pharmacy, which provides patients with end to end NHS digital pharmacy service to patients across England has also acquired Truepill’s NHS patient base. 

Expansion plans

The company intends to expand its UK workforce, which currently numbers 90 people, and all of Truepill UK’s existing pharmacy and warehouse personnel have been offered positions with Phlo.

Nadeem Sarwar, Founder and CEO of Phlo, comments, “Phlo’s acquisition of Truepill UK marks a hugely significant moment in the evolution of digital healthcare in the UK. We’re delighted that this market consolidation will enable further improvements to the excellent service that Phlo offers to patients and partners, and also allow us to extend that service by welcoming new patients and partners across the country. I’d like to thank the team at Truepill for their assistance in making the sale a smooth one and for their commitment to their patients and partners during this time.” 

Jason McGibbon, Chairman of Phlo, comments, “The Truepill deal caps an incredibly busy and successful six-month period for the team.  Fuelled by our successful Series A raise, the Truepill acquisition will accelerate our digital healthcare strategy throughout the remainder of 2023 and beyond.  The levels of commitment from the Truepill team in effecting a smooth transition have been outstanding, and we are looking forward to working together to fuel the next phase of our growth.”  

“Following our Series A raise, Phlo is in a stronger position than ever to lead digital transformation in the pharmacy sector and to play a pivotal role in improving health outcomes in the UK.” 

Shakil Ahmed, Truepill UK Managing Director, comments, “As Truepill made the decision to focus on the US market, our priority was to ensure our UK patients, clients and staff faced as little disruption as possible.  “Our priority was to find the right acquirer who shares Truepill’s vision and ethos of the future of pharmacy. That meant finding a business that is patient focused, with a strong technology stack and who were committed to growing and innovating in the UK market with a focus on servicing current and future consumer health clients. In Phlo, we found a company which shared all these objectives, and I don’t think we could have found a better fit. I am delighted to be continuing an ongoing commercial partnership with Phlo that will allow our US partners to launch in the UK in the future.” 

Phlo, which was founded in Glasgow in 2019, offers same-day drug deliveries that patients can track via a smartphone app. The organisation provides one-time and recurrent prescription deliveries from the NHS and private healthcare providers, as well as medicine expiration reminders.

In addition, the company provides a digital pharmacy API that interfaces with healthcare providers like Babylon and HealthHero to deliver services such as digital prescriptions and real-time patient updates.

Related Posts
Total
0
Share

Get daily funding news briefings in the tech world delivered right to your inbox.

Enter Your Email
join our newsletter. thank you